| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.003 |